ed silverman (@edsilverman) 's Twitter Profile
ed silverman

@edsilverman

Pharmalot columnist and senior writer at @STATnews.. former WSJer.. proud dad; likes music, dogs and taking naps

ID: 17445167

linkhttp://www.statnews.com/pharmalot/ calendar_today17-11-2008 17:00:17

282 Tweet

5,5K Followers

144 Following

ed silverman (@edsilverman) 's Twitter Profile Photo

Eli Lilly is making some dramatic cuts to list prices of its insulin products.. Matthew Herper & I spoke to CEO David Ricks, and also to several experts and a patient advocate who were hopeful but a bit skeptical. statnews.com/pharmalot/2023… #pharma #diabetes #insulin $LLY $SNY $NVO

ed silverman (@edsilverman) 's Twitter Profile Photo

European Union drug pricing proposal for the pandemic treaty generates pushback.. statnews.com/pharmalot/2023… #pharma #pandemic #WHO

ed silverman (@edsilverman) 's Twitter Profile Photo

ā€˜True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J.. statnews.com/pharmalot/2023… #pharma #diabetes $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

Gilead defeats federal government in closely watched battle over patents for HIV prevention pills.. statnews.com/pharmalot/2023… #pharma #patents #HIV #AIDS #CDC #HHS $GILD

ed silverman (@edsilverman) 's Twitter Profile Photo

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results.. statnews.com/pharmalot/2023… #pharma #SEC #insidertrading #Paxlovid $PFE

ed silverman (@edsilverman) 's Twitter Profile Photo

Drug wholesaler owner indicted for alleged role in diverting Gilead and J&J HIV medicines.. read the indictment here.. statnews.com/pharmalot/2023… #pharma #HIV #counterfeit $GILD $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries.. statnews.com/pharmalot/2023… #pharma #patents #TB #tuberculosis #medicine $JNJ

ed silverman (@edsilverman) 's Twitter Profile Photo

Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV.. statnews.com/pharmalot/2023… #pharma #patent #HIV #AIDS #Colombia $GSK $PFE

ed silverman (@edsilverman) 's Twitter Profile Photo

Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?.. my latest column.. feedback, suggestions, criticism are welcome.. statnews.com/2023/10/04/amg…… #pharma #biotech #cancer #FDA #transparency #clinicaltrials $AMGN

ed silverman (@edsilverman) 's Twitter Profile Photo

ā€˜We’ve exhausted all avenues’: A small biotech may give up on its ultra-rare disease drug over frustration with FDA.. statnews.com/pharmalot/2023… #pharma #biotech #FDA #raredisease #orphandrug

ed silverman (@edsilverman) 's Twitter Profile Photo

Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace.. statnews.com/pharmalot/2023… #pharma #biotech #biosimilar #patents

ed silverman (@edsilverman) 's Twitter Profile Photo

When it comes to policing pharma, the FTC says it’s on ā€˜an incredible winning streak’.. statnews.com/pharmalot/2024… #pharma #FTC #antitrust #monopoly #Biden #rebates #patents #mergers $CVS $AMGN $UNH $CI $GSK $AZN $SNY

ed silverman (@edsilverman) 's Twitter Profile Photo

Pricey sickle cell treatments raise daunting new challenges for Medicaid programs.. statnews.com/pharmalot/2024… #pharma #sicklecell #Medicaid $VRTX $CRSP $BLUE

ed silverman (@edsilverman) 's Twitter Profile Photo

CMS will use outcomes-based agreements in bid to help Medicaid pay for sickle cell gene therapies.. statnews.com/pharmalot/2024… #pharma #Medicaid #CMS #medicines #sicklecell $VRTX $CRSP $BLUE

ed silverman (@edsilverman) 's Twitter Profile Photo

After nearly 30 years covering pharma, you might think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET.. click on this STAT+ Connect link to sign up... connect.statnews.com/landing

After nearly 30 years covering pharma, you might  think I know it all. Here's your chance to find out... you can Ask Me Anything on Thursday, Feb. 15 at 1 pm ET..  click on this STAT+ Connect  link to sign up...

connect.statnews.com/landing
ed silverman (@edsilverman) 's Twitter Profile Photo

ā€œThe messages are filled with misinformation that is hard to set straight because it is such a complicated topic and patients are made to feel like their lives are at stake" statnews.com/pharmalot/2024… #pharma #RareDiseases #medicines #drugs #Colorado #Enbrel $AMGN $VRTX

ed silverman (@edsilverman) 's Twitter Profile Photo

ā€œColombia is planting a flag for global health equity,ā€ said Peter Maybarduk of Public Citizen. ā€œThis will inspire new challenges to patent barriers and improve treatment access, towards an AIDS-free generation." statnews.com/pharmalot/2024… #patents #medicines #Colombia #HIV $GSK

ed silverman (@edsilverman) 's Twitter Profile Photo

ā€œā€œThe whole purpose of biosimilars was to introduce competition into the marketplace," said study author Ben Rome. "...The fact that it’s so hard to find savings consistently is disappointing." statnews.com/pharmalot/2024… #pharma #biotech #biologics #biosimilars #medicines

ed silverman (@edsilverman) 's Twitter Profile Photo

Student group that ranked med schools over industry conflicts votes to accept pharma funding.. statnews.com/pharmalot/2024… #pharma #medicine #MedicalEducation #medschool #conflicts

ed silverman (@edsilverman) 's Twitter Profile Photo

FDA scolds Merz over ā€˜misleading’ Instagram posts featuring interior designer Nate Berkus.. statnews.com/pharmalot/2024…… #pharma #FDA #botox #wrinkles #Instagram